The risk of constructing any new managed access process within the current application of HTA policy risks the creation of another rarely used process that will not benefit the people a public health program is designed to serve. …
No need for reviews or new processes, just lead and direct them to do it
June 26, 2023 Latest NewsBioPharmaComment
Latest Video
New Stories
-
An argument that fails based on its own research findings
October 20, 2026 - - Latest News -
Be very careful about arguing for more pricing legislation, because you might just get it
October 20, 2026 - - Latest News -
Algorae signs two-part deal with Umedica to expand Australian portfolio
October 19, 2026 - - Latest News -
Novartis, Boehringer Ingelheim leaders join Medicines Australia board
October 19, 2026 - - Latest News -
The 'Dispatched' Podcast - Series 5. Ep.36
October 19, 2026 - - Podcast -
'If your doctor prescribes it, it should be covered,' pollster recommends as the key message
October 19, 2026 - - Latest News -
Cancer physicians now running communication skills workshops on how to discuss private pay
October 19, 2026 - - Latest News